Complement receptor immunoglobulin: a control point in infection and immunity, inflammation and cancer

Complement receptor immunoglobulin: a control point in infection and immunity, inflammation and cancer

Bibliographic Details
Main Authors:	Annabelle Grace Small, Marwah Al-Baghdadi, Alex Quach, Charles Hii, Antonio Ferrante
Format:	Article
Language:	English
Published:	SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2016-03-01
Series:	Swiss Medical Weekly
Subjects:	Cancer CRIg-Fc fusion protein CRIg/VSIG4/Z39Ig cytokines dendritic cells infection and immunity
Online Access:	https://www.smw.ch/index.php/smw/article/view/2171

Similar Items

V-Set and immunoglobulin domain containing (VSIG) proteins as emerging immune checkpoint targets for cancer immunotherapy
by: Xia Zhou, et al.
Published: (2022-09-01)

CRIg, a tissue-resident macrophage specific immune checkpoint molecule, promotes immunological tolerance in NOD mice, via a dual role in effector and regulatory T cells
by: Xiaomei Yuan, et al.
Published: (2017-11-01)

Microbial DNA Enrichment Promotes Adrenomedullary Inflammation, Catecholamine Secretion, and Hypertension in Obese Mice
by: Hong Gao, et al.
Published: (2022-02-01)

Structural biology of complement receptors
by: Jorge Santos-López, et al.
Published: (2023-09-01)

V-Set and Immunoglobulin Domain-Containing 1 (VSIG1), Predominantly Expressed in Testicular Germ Cells, Is Dispensable for Spermatogenesis and Male Fertility in Mice
by: Yena Jung, et al.
Published: (2021-04-01)

The Functional Role of IgA in the IgM/IgA-Enriched Immunoglobulin Preparation Trimodulin
by: Fabian Bohländer, et al.
Published: (2021-12-01)

Upregulation of VSIG4 in Type 2 Diabetic Kidney Disease
by: Sang Youb Han, et al.
Published: (2022-07-01)

Physiological and Pathological Inflammation Induced by Antibodies and Pentraxins
by: Chiara Elisabeth Geyer, et al.
Published: (2021-05-01)

The Role of V-Set Ig Domain-Containing 4 in Chronic Kidney Disease Models
by: Sang Youb Han, et al.
Published: (2023-01-01)

IgD/FcδR is involved in T-cell acute lymphoblastic leukemia and regulated by IgD-Fc-Ig fusion protein
by: Yujing Wu, et al.
Published: (2023-03-01)

Gut lumen-leaked microbial DNA causes myocardial inflammation and impairs cardiac contractility in ageing mouse heart
by: Hong Gao, et al.
Published: (2023-07-01)

Perspective view of allogeneic IgG tumor immunotherapy
by: Ying Liu, et al.
Published: (2024-03-01)

Comparative Analysis of Fcγ and Complement Receptors Presence on Monocytes in Pulmonary Sarcoidosis and Tuberculosis
by: Marlena Typiak, et al.
Published: (2023-06-01)

On the complexity of IgE: The role of structural flexibility and glycosylation for binding its receptors
by: Kevin Plattner, et al.
Published: (2023-03-01)

Complement protein and Immunoglobulins Serum levels in Normal Pregnant and Spontaneous Aborted Women
by: Hiwa Abdulrahman Ahmad, et al.
Published: (2018-07-01)

Regulation of T Cell Activities in Rheumatoid Arthritis by the Novel Fusion Protein IgD-Fc-Ig
by: Jing Zhang, et al.
Published: (2020-05-01)

FcεRI deficiency alleviates silica-induced pulmonary inflammation and fibrosis
by: Yiling Chen, et al.
Published: (2022-10-01)

Afucosylated IgG Targets FcγRIV for Enhanced Tumor Therapy in Mice
by: Rens Braster, et al.
Published: (2021-05-01)

B7 Family Molecule VSIG4 Regulates Intestinal Anti-<i>Enterohemorrhagic Escherichia coli</i> Immunity by Altering Gut Flora Diversity
by: Zhili He, et al.
Published: (2021-08-01)

VISTA and its ligands: the next generation of promising therapeutic targets in immunotherapy
by: Najibeh Shekari, et al.
Published: (2023-11-01)

VSIG4 Silencing Inhibits Glioblastoma Growth by Regulating the JAK2/STAT3 Pathway
by: Zheng C, et al.
Published: (2023-06-01)

Low expression of VSIG4 is associated with poor prognosis in hepatocellular carcinoma patients with hepatitis B infection
by: Zhu S, et al.
Published: (2018-09-01)

Fc Engineering Strategies to Advance IgA Antibodies as Therapeutic Agents
by: Geert van Tetering, et al.
Published: (2020-12-01)

Fc-Receptor Targeted Therapies for the Treatment of <i>Myasthenia gravis</i>
by: Christian W. Keller, et al.
Published: (2021-05-01)

Differences between Human and Mouse IgM Fc Receptor (FcµR)
by: Hiromi Kubagawa, et al.
Published: (2021-06-01)

FcRN receptor antagonists in the management of myasthenia gravis
by: Vinaya Bhandari, et al.
Published: (2023-08-01)

Design of a multi-epitope vaccine against brucellosis fused to IgG-fc by an immunoinformatics approach
by: Aodi Wu, et al.
Published: (2023-10-01)

Distinct effector functions mediated by Fc regions of bovine IgG subclasses and their interaction with Fc gamma receptors
by: Alistair Noble, et al.
Published: (2023-11-01)

Study on FcγRn Electrochemical Receptor Sensor and Its Kinetics
by: Dandan Peng, et al.
Published: (2020-07-01)

Mutations of Recombinant Aquaporin-4 Antibody in the Fc Domain Can Impair Complement-Dependent Cellular Cytotoxicity and Transplacental Transport
by: Simone Mader, et al.
Published: (2018-07-01)

IgA2 immune complexes selectively promote inflammation by human CD103+ dendritic cells
by: Lynn Mes, et al.
Published: (2023-03-01)

Tracing the Origins of IgE, Mast Cells, and Allergies by Studies of Wild Animals
by: Lars Torkel Hellman, et al.
Published: (2017-12-01)

Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT+): interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis
by: James F. Howard, et al.
Published: (2024-01-01)

Identification of the Linear Fc-Binding Site on the Bovine IgG1 Fc Receptor (boFcγRIII) Using Synthetic Peptides
by: Ruining Wang, et al.
Published: (2024-01-01)

Antibodies and their receptors: different potential roles in mucosal defence
by: Rachel eHorton, et al.
Published: (2013-07-01)

Elements of Immunoglobulin E Network Associate with Aortic Valve Area in Patients with Acquired Aortic Stenosis
by: Daniel P. Potaczek, et al.
Published: (2020-12-01)

Anti-HIV-1 Nanobody-IgG1 Constructs With Improved Neutralization Potency and the Ability to Mediate Fc Effector Functions
by: Angela I. Schriek, et al.
Published: (2022-05-01)

Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions
by: Angela I. Schriek, et al.
Published: (2022-11-01)

Functions of IgM fc receptor (FcµR) related to autoimmunity
by: Hiromi Kubagawa, et al.
Published: (2024-12-01)

Non-neutralizing functions in anti-SARS-CoV-2 IgG antibodies
by: Sebastian Reinig, et al.
Published: (2024-02-01)